ClinicalTrials.gg
Not yet recruitingNCT06124092APCIUpdated Nov 9, 2023

Outcomes of Children After Hospitalization in Intensive Care Unit

An observational study in Renal Disease, Liver Diseases and Heart Diseases, sponsored by St. Justine's Hospital. Not yet recruiting at 8 sites in Canada. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2023-11-09.

Sponsored by St. Justine's Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
690
Ages
Up to 18 Years
Sex
All
01

Study summary

More than 10,000 children are hospitalized in an PICU every year in Canada. While most of them will survive their PICU hospitalization and their critical illness, some children will not recover to their pre-illness level. Some may develop behavioral, physical, emotional or developmental problems and difficulties at school. All these problems are elements that are part of the Pediatric Post-Intensive Care Syndrome (PICS-p).

It is important to understand the elements (risk factors) that play a role in the development of PICS-p. In Canada, there is no systematic follow-up for children after they leave the PICU. Understanding what can cause PICS-p (risk factors) and how much PICS-p has an impact on children and their family is very important to the family well-being.

Read the detailed description

The Pediatric Post-Intensive Care Syndrome (PICS-p) is a newly developed conceptual framework that incorporates the constellation of morbidities that are increasingly recognized to affect children and their families after a critical illness. Experts define PICS-p as a new or worsening impairment in any of the following 5 domains of child health: physical, cognitive, emotional, social, or family.

In contrast to well established follow-up programs in adults, there is currently a lack of systematic follow-up of PICU survivors which prevents both the recognition and management of PICS-p. The absence of granular, empirical data on the recovery of PICU children impedes both the identification and management of PICS-p.

This project is a prospective Canadian multicenter cohort study to identify risk factors of PICS-p, develop and validate a predictive model for PICS-p to detect at-risk children, characterize each domain of PICS-p over two years post critical illness and uncover additional morbidities that are not captured using the current PICS-p framework. This study will provide granular, empirical data on which to build developmentally appropriate and tailored screening, management, and intervention programs during and after PICU to improve the global recovery of critically ill children and their family.

02

Conditions studied

  • Renal Disease
  • Liver Diseases
  • Heart Diseases
  • Trauma Injury
  • Sepsis
  • Septic Shock
  • Pneumonia
  • Bronchiolitis

Keywords

  • Pediatric Intensive Care Unit
  • PICU
03

In context

Kidney Diseases

969 studies on the registry are indexed under Kidney Diseases; 183 are open to participants now.

This study's planned enrollment of 690 is above the median of 245 across 277 observational studies indexed under Kidney Diseases.

Browse Kidney Diseases studies →

Lead sponsor

St. Justine's Hospital is the lead sponsor of 156 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patient admitted to Pediatric Intensive Care Unit for 96 hours or more will be included in the study unless they age a gestionnal age \<37 weeks or are over 18 years-old or were admitted to PICu for congenital heart surgery (as they are followed in neuro-cardiac clinic) and for whom the life expectancy is less than 1 year.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children ≤18yo hospitalized in PICU for ≥96 hours

Exclusion criteria

Exclusion Criteria:

  1. gestational age \<37 weeks or age >18 years at PICU entry;
  2. admitted for congenital heart surgery (followed in neuro-cardiac clinics in most centers);
  3. anticipated \<1year (e.g., active do not resuscitate status).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
690 participants (estimated)
Patient registry
No

Interventions

  • Otherneurocognitive tests

    Cohort study: all parents and participants will have questionnaires to complete, based on participant's age.

    Also known as: Quality of life

06

What researchers measure

Primary outcomes

  1. Identify risk factors of PICS-p at 2 months post-PICU

    Identification of modifiable and non-modifiable risk factors

    Time frame: 2 months after PICU discharge

  2. Develop and validate a model predictive of PICS-p 2 months post PICU

    The model will allow detection at PICU discharge of children in need of post-PICU follow-up

    Time frame: 2 months after PICU discharge

Secondary outcomes

  1. Describe the incidence of each of the five domains of PICS-p across the first two years post-PICU

    Identify which domain gets impacted and when during the course of the follow-up

    Time frame: At 2 months, 12, 18 months and 36 months post PICU discharge

  2. Uncover additional post-PICU morbidities not detected within the framework of PICS-p.

    Detection of morbidities through the medical provider interview that are not included in the current framework.

    Time frame: Until 36 months post PICU discharge

Other outcomes

  1. Describe families' healthcare requirements throughout their recovery process after PICU.

    Descrie the variety of healthcare professional and medical required post PICU hospitalization.

    Time frame: Until 36 months post PICU discharge

07

Study locations

8 sites
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2024; primary completion for Mar 2027, 36 months later.

Of 99 non-industry observational studies under Kidney Diseases, half reached primary completion within 68 months of starting (the median), counting those still running; a quarter within 33. This study's planned 36 months is below that.

Counting every sponsor, half of 116 studies reached it within 59 months; a quarter within 28 and three quarters within 118.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2023
First posted
Nov 9, 2023
StartEst.
Mar 2024
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2029
Last update
Nov 9, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06124092
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Genevieve Du Pont-Thibodeau (MD, St. Justine's Hospital) — Principal investigator
First posted
Nov 9, 2023
Start date
Mar 2024 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
Mar 2029 (estimated)
Last update
Nov 9, 2023

Study contacts

Geneviève Du Pont-Tibodeau, MD
Contact
genevieve.du.pont-thibodeau.med@ssss.gouv.qc.ca
514-345-4931 ext. 5553
Laurence Ducharme-Crevier, MD
Contact
laurence.ducharme.crevier.med@ssss.gouv.qc.ca
514-345-4931 ext. 4118
Geneviève Du Pont-Thibodeau, MD
principal investigator · St. Justine's Hospital
Laurence Cucharme-Crevier, MD
principal investigator · St. Justine's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion